NCT06769698
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06769698
Title A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Orlando Health RECRUITING Orlando Florida 32806 United States Details
Emory University School of Medicine RECRUITING Atlanta Georgia 30308 United States Details
St. Elizabeth Healthcare RECRUITING Edgewood Kentucky 41017 United States Details
Norton Cancer Institute RECRUITING Louisville Kentucky 40202 United States Details
Oncology Hematology West P.C. dba Nebraska Cancer Specialists RECRUITING Omaha Nebraska 68130 United States Details
Ohio State University RECRUITING Columbus Ohio 43210 United States Details
Vanderbilt-Ingram Cancer Center RECRUITING Nashville Tennessee 37232 United States Details
Joe Arrington Cancer Research & Treatment Center RECRUITING Lubbock Texas 79410 United States Details
Inova Schar Cancer Institute RECRUITING Fairfax Virginia 22031 United States Details
Peter MacCallum Cancer Centre (PMCC) RECRUITING Melbourne Victoria 3050 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field